One thing you can say is that the stock has performed well this year relative to the rest of the market even though the business hasn’t delivered revenue on the test yet.
Ann: UK NICE publishes Medtech Innovation Briefing on PromarkerD, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.010(1.27%) |
Mkt cap ! $104.8M | |||
| Open | High | Low | Value | Volume |
| 79.0¢ | 80.0¢ | 78.0¢ | $68.28K | 86.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7412 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 8000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |